Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study

NCT01181505 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT01181505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01181505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study
Lead sponsor
Inje University
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2007
Completion date
June 30, 2008
Enrollment
31 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

genotype guided(hnf4a), healthy subjects